11 – 20 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
(
- Contribution to journal › Article
-
Mark
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
(
- Contribution to journal › Article
- 2019
-
Mark
CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Swedish Version of the Hayling Test : Clinical Utility in Frontotemporal Dementia Syndromes
(
- Contribution to journal › Article
- 2018
-
Mark
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia
(
- Contribution to journal › Article
-
Mark
Will FTLD-tau work for all when FTDP-17 retires?
(
- Contribution to journal › Article
-
Mark
Slowly progressive dementia caused by MAPT R406W mutations : Longitudinal report on a new kindred and systematic review
(
- Contribution to journal › Article
- 2017
-
Mark
Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
(
- Contribution to journal › Article